Role of Supermicrosurgical LVA for Lower Limb Lymphedema

Chang Gung Memorial Hospital131 enrolled

Overview

Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticovenous anastomosis (LVA) for treating severe lymphedema. This study hypothesizes whether LVA can be performed on post-VLNT patients seeking further improvement.

Study Type

OBSERVATIONAL

Enrollment

131

Conditions

Lymphedema

Interventions

Vascularized lymph node flap transferOTHER

Patients who have received VLNT as their primary treatment but with minimal improvement

Patients without prior lymphedema surgeryOTHER

Patients without prior lymphedema surgery

Eligibility

Sex: ALLMin age: 20 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * From November 2014 to January 2019 * Lower limb lymphedema patients Exclusion Criteria: * Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.

Locations (1)

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan

Outcomes

Primary Outcomes

Magnetic resonance volumetry

Magnetic resonance volumetry was used for measuring preoperative and postoperative volume changes at least 6-month after LVA.

Time frame: 6 months after LVA

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.